Tianjin Haida Venture Capital Management
VC Fund
Tianjin, China
Tianjin Haida Venture Capital Management is a VC fund in Tianjin focused on Medical and Health Care. Tianjin Haida Venture Capital Management Co., Ltd. (abbreviation: Haida Investment) was established in 2007 with a management capital of RMB 5 billion. The core team started in 2000 and is composed of the first batch of professionals engaged in equity investment in China. It has nearly 20 years of experience in equity investment management. Thecore team has been working closely for more than 15 years and is one of the longest professional teams in the domestic venture capital industry.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 55%
Last updated:
For AI agents: llms.txt
Industries Tianjin Haida Venture Capital Management invests in
Stages Tianjin Haida Venture Capital Management invests in
Countries Tianjin Haida Venture Capital Management invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Medical 4 (36%)
- Health Care 4 (36%)
- Medical Device 3 (27%)
- Biotechnology 2 (18%)
- Manufacturing 2 (18%)
Stage
- Series A 4 (36%)
- Series B 3 (27%)
- Angel 1 (9%)
- Series C 1 (9%)
- Series D 1 (9%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Liu Jie
Executive general manager
|
Executive general manager | Total investments: 0 | Find email | |
Wang Wengang
Chairman and general manager
|
Chairman and general manager | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Curatia Medical
|
Curatia Medical is committed to developing, manufacturing, and selling disposables in cardiac, peripheral, neuro, and pulmonary applications. They are an interventional disposables company that is FDA, TUV, and CFDA-approved. | Series A / Jan 04, 2026 | |
MetWare
|
Maiwei Metabolism is a developer of novel medical metabolic technology, specializing in the use of cutting-edge metabolomics technology in the domains of life science research and medicine. | Series B / Apr 02, 2024 | |
Dearer Medical
|
Dearer Medical is a medical device company that specializes in the development, production, and sales of eye-related medical products such as color contact lenses. | Series C / Jan 22, 2024 | |
|
Curatia Medical
|
Curatia Medical is committed to developing, manufacturing, and selling disposables in cardiac, peripheral, neuro, and pulmonary applications. They are an interventional disposables company that is FDA, TUV, and CFDA-approved. | Angel / Jul 21, 2022 | |
|
Curatia Medical
|
Curatia Medical is committed to developing, manufacturing, and selling disposables in cardiac, peripheral, neuro, and pulmonary applications. They are an interventional disposables company that is FDA, TUV, and CFDA-approved. | Venture - Series Unknown / Jul 21, 2022 | |
Maxone Semi
|
Strong One Semiconductor is a supplier of IC wafer test probe cards. | Series D / Jun 09, 2022 | |
|
Maxone Semi
|
Strong One Semiconductor is a supplier of IC wafer test probe cards. | Series B / Jun 01, 2022 | |
Aucta Pharmaceuticals China
|
Aucta Pharmaceuticals China is a provider of a drug development platform intended to improve drug delivery. | $15.6M / Series A / Nov 04, 2021 | |
Universal Medical Imaging
|
Universal Medical Imaging Diagnostic has partnered domestic hospitals to offer imaging devices for precise disease detection. | $85.9M / Series B / Feb 10, 2020 | |
Kanghua Biotechnology
|
Kanghua Biotechnology is a developer of diagnostic reagents. | Series A / Feb 26, 2019 | |
| See all 11 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Tianjin Haida Venture Capital Management invest in?
Tianjin Haida Venture Capital Management invests primarily in Medical, Health Care and Medical Device startups, most often at Series A and Series B stage. Most of the 11 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Tianjin Haida Venture Capital Management?
Public channels for Tianjin Haida Venture Capital Management include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Tianjin Haida Venture Capital Management?
The team at Tianjin Haida Venture Capital Management includes Liu Jie (Executive general manager) and Wang Wengang (Chairman and general manager). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
